Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : SPT-2101
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Study Phase : Phase I
Sponsor : Savoir Capital
Deal Size : $8.2 million
Deal Type : Financing
Spiral Therapeutics Completes $8.25M Financing and Initiates Phase 2 Trial in Meniere's Disease
Details : SPT-2101 is a sustained-release steroid formulation designed for precise inner ear administration using Spiral's novel delivery procedure. Spiral recently completed enrollment of an open label pilot clinical study of SPT-2101 in 10 patients with Meniere'...
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
January 10, 2023
Lead Product(s) : SPT-2101
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Highest Development Status : Phase I
Sponsor : Savoir Capital
Deal Size : $8.2 million
Deal Type : Financing
Reset All
